Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
出版年份 2018 全文链接
标题
Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
作者
关键词
-
出版物
Frontiers in Molecular Neuroscience
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-05-15
DOI
10.3389/fnmol.2018.00153
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Divalproex sodium modulates nuclear localization of ataxin-3 and prevents cellular toxicity caused by expanded ataxin-3
- (2018) Zi-Jian Wang et al. CNS Neuroscience & Therapeutics
- The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin
- (2018) Bo Wang et al. NEUROBIOLOGY OF DISEASE
- Contribution of Neuroepigenetics to Huntington’s Disease
- (2017) Laetitia Francelle et al. Frontiers in Human Neuroscience
- Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease
- (2017) Luana Naia et al. JOURNAL OF NEUROSCIENCE
- Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17
- (2017) Yang Yang et al. JOURNAL OF NEUROSCIENCE
- Therapies targeting DNA and RNA in Huntington's disease
- (2017) Edward J Wild et al. LANCET NEUROLOGY
- Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
- (2017) Nagaraj S. Moily et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels
- (2017) Libo Yu-Taeger et al. NEUROPHARMACOLOGY
- Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
- (2017) Cristina Cariulo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Class I Histone Deacetylases in a “Complex” Environment
- (2017) Christopher J. Millard et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
- (2017) Wojciech J. Szlachcic et al. Frontiers in Molecular Neuroscience
- Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases
- (2017) Fabio Sambataro et al. Frontiers in Molecular Neuroscience
- Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3
- (2017) Yu-Ling Wu et al. Scientific Reports
- Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
- (2016) Anna Rocchi et al. ACTA NEUROPATHOLOGICA
- Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding
- (2016) Maxmore Chaibva et al. BIOPHYSICAL JOURNAL
- Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin
- (2016) Li Lin et al. BRAIN RESEARCH
- Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway
- (2016) Melanie Vanessa Halbach et al. CEREBELLUM
- Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's diseasein vitromodel
- (2016) Mijung Lee et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Allele-specific regulation of mutantHuntingtinby Wig1, a downstream target of p53
- (2016) Sun-Hong Kim et al. HUMAN MOLECULAR GENETICS
- Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington’s disease
- (2016) Abhishek Chandra et al. HUMAN MOLECULAR GENETICS
- Huntingtin N17 domain is a reactive oxygen species sensor regulating huntingtin phosphorylation and localization
- (2016) Laura F. DiGiovanni et al. HUMAN MOLECULAR GENETICS
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice
- (2016) Ian H. Kratter et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models
- (2016) Luana Naia et al. MOLECULAR NEUROBIOLOGY
- PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes In Vivo
- (2016) Joseph Ochaba et al. NEURON
- Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
- (2016) Vahri Beaumont et al. NEURON
- Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways
- (2016) Melissa Ingram et al. NEURON
- Safety and efficacy of valproic acid treatment in SCA3/MJD patients
- (2016) Li-Fang Lei et al. PARKINSONISM & RELATED DISORDERS
- The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53
- (2016) Hongmei Liu et al. PLOS BIOLOGY
- Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach
- (2016) Louise-Laure Mariani et al. JAMA Neurology
- ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation
- (2016) Tina Zimmermann et al. Stem Cell Reports
- Genomic Instability Associated with p53 Knockdown in the Generation of Huntington’s Disease Human Induced Pluripotent Stem Cells
- (2016) Andrew M. Tidball et al. PLoS One
- The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice
- (2016) Haiqun Jia et al. PLoS One
- miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington’s Disease Monkey Neural Cells
- (2016) Tanut Kunkanjanawan et al. PLoS One
- Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model
- (2015) Abiodun Ajayi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation
- (2015) A-ram Kang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
- (2015) Sigurd D. Süssmuth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD)
- (2015) Tamara Ratovitski et al. CELL CYCLE
- Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway
- (2015) Wojciech J. Szlachcic et al. Disease Models & Mechanisms
- Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor–mediated disease
- (2015) Jason P. Chua et al. JOURNAL OF CLINICAL INVESTIGATION
- Sulforaphane Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity by Activating the Keap1-Nrf2-ARE Pathway and Inhibiting the MAPKs and NF-κB Pathways
- (2015) Minhee Jang et al. MOLECULAR NEUROBIOLOGY
- Acetylation site specificities of lysine deacetylase inhibitors in human cells
- (2015) Christian Schölz et al. NATURE BIOTECHNOLOGY
- A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease
- (2015) Kristina Bečanović et al. NATURE NEUROSCIENCE
- MicroRNA-124 slows down the progression of Huntington′s disease by promoting neurogenesis in the striatum
- (2015) Manho Kim et al. Neural Regeneration Research
- The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster
- (2015) Wei-Ling Tsou et al. NEUROBIOLOGY OF DISEASE
- Protein Arginine Methyltransferase 6 Enhances Polyglutamine-Expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy
- (2015) Chiara Scaramuzzino et al. NEURON
- Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice
- (2015) Shanshan Huang et al. Cell Reports
- HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
- (2014) Ulrike Träger et al. BRAIN
- Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms
- (2014) Minhee Jang et al. BRAIN BEHAVIOR AND IMMUNITY
- Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease
- (2014) Surbhi Gupta et al. BRAIN RESEARCH BULLETIN
- Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis
- (2014) Amit Kumar et al. DRUG DISCOVERY TODAY
- Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology
- (2014) Megha Maheshwari et al. HUMAN MOLECULAR GENETICS
- Deactivation of TBP contributes to SCA17 pathogenesis
- (2014) Tun-Chieh Hsu et al. HUMAN MOLECULAR GENETICS
- The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1
- (2014) Anand Venkatraman et al. HUMAN MOLECULAR GENETICS
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Valproic acid attenuates the suppression of acetyl histone H3 and CREB activity in an inducible cell model of Machado–Joseph disease
- (2014) X.P. Lin et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Transcription, Epigenetics and Ameliorative Strategies in Huntington’s Disease: a Genome-Wide Perspective
- (2014) Luis M. Valor MOLECULAR NEUROBIOLOGY
- Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7
- (2014) Jennifer Y Tan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington’s Disease
- (2014) Joshua L. Plotkin et al. NEURON
- Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones
- (2014) Davide Schiffer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation
- (2014) Haiqun Jia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A
- (2014) K. P. Bhat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sirtuin 1 activator SRT2104 protects Huntington's disease mice
- (2014) Mali Jiang et al. Annals of Clinical and Translational Neurology
- Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington’s disease
- (2013) Hsin Hsien Yeh et al. BRAIN RESEARCH
- Second Cistron in CACNA1A Gene Encodes a Transcription Factor Mediating Cerebellar Development and SCA6
- (2013) Xiaofei Du et al. CELL
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
- (2013) Albert Giralt et al. HIPPOCAMPUS
- A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
- (2013) Han-Yun Hsiao et al. HUMAN MOLECULAR GENETICS
- Direct Inhibition of Gcn5 Protein Catalytic Activity by Polyglutamine-expanded Ataxin-7
- (2013) Tara L. Burke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lithium Down-regulates Histone Deacetylase 1 (HDAC1) and Induces Degradation of Mutant Huntingtin
- (2013) Shuai Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models
- (2013) Paola Conforti et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
- (2013) Jing Jin et al. JOURNAL OF NEUROCHEMISTRY
- The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients
- (2013) Robert B. Laprairie et al. JOURNAL OF NEUROIMMUNOLOGY
- Herpes Simplex Virus 1 E3 Ubiquitin Ligase ICP0 Protein Inhibits Tumor Necrosis Factor Alpha-Induced NF-κB Activation by Interacting with p65/RelA and p50/NF-κB1
- (2013) Jie Zhang et al. JOURNAL OF VIROLOGY
- Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation
- (2013) M. Dhruba Singh et al. NEUROBIOLOGY OF DISEASE
- Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4
- (2013) Jiping Yi et al. PLoS One
- Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease
- (2013) Wooseok Im et al. PLoS One
- SUMO-2 and PIAS1 Modulate Insoluble Mutant Huntingtin Protein Accumulation
- (2013) Jacqueline Gire O’Rourke et al. Cell Reports
- PPARGC1A/PGC-1α, TFEB and enhanced proteostasis in Huntington disease
- (2012) Albert R. La Spada Autophagy
- In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice
- (2012) P Conforti et al. GENE THERAPY
- Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2
- (2012) S. T. Hansen et al. HUMAN MOLECULAR GENETICS
- A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset†
- (2012) Selma M. Soyal et al. HUMAN MOLECULAR GENETICS
- Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease
- (2012) Rajnish Kumar Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Sp1 Regulates Human Huntingtin Gene Expression
- (2012) Ruitao Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS
- (2012) Sanjeev Rajakulendran et al. Nature Reviews Neurology
- DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles
- (2012) Kazushi Suzuki et al. NEUROBIOLOGY OF DISEASE
- Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease
- (2012) Haiqun Jia et al. NEUROBIOLOGY OF DISEASE
- Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
- (2012) Alessandro Leuti et al. NEUROBIOLOGY OF DISEASE
- SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo
- (2012) Anna Bobrowska et al. PLoS One
- Temporal Separation of Aggregation and Ubiquitination during Early Inclusion Formation in Transgenic Mice Carrying the Huntington’s Disease Mutation
- (2012) Belvin Gong et al. PLoS One
- Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes
- (2012) S. D. McCullough et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Sirtuin 2 Inhibitor AK-7 Is Neuroprotective in Huntington’s Disease Mouse Models
- (2012) Vanita Chopra et al. Cell Reports
- Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntington's Disease Treatment
- (2011) Jun Wu et al. CHEMISTRY & BIOLOGY
- Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model
- (2011) Yi Chun Chen et al. HUMAN MOLECULAR GENETICS
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease
- (2011) Ashu Johri et al. HUMAN MOLECULAR GENETICS
- A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome
- (2011) Jie Ren et al. HUMAN MOLECULAR GENETICS
- Mithramycin Is a Gene-Selective Sp1 Inhibitor That Identifies a Biological Intersection between Cancer and Neurodegeneration
- (2011) S. F. Sleiman et al. JOURNAL OF NEUROSCIENCE
- SIRT1 Modulates Aggregation and Toxicity through Deacetylation of the Androgen Receptor in Cell Models of SBMA
- (2011) H. L. Montie et al. JOURNAL OF NEUROSCIENCE
- Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's Disease
- (2011) Z. Xiang et al. JOURNAL OF NEUROSCIENCE
- Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
- (2011) Hong Van B Che et al. Molecular Neurodegeneration
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
- (2011) Mali Jiang et al. NATURE MEDICINE
- Truncated Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Splice Variant Is Severely Altered in Huntington’s Disease
- (2011) Ashu Johri et al. Neurodegenerative Diseases
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin
- (2011) A. Grison et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward understanding Machado–Joseph disease
- (2011) Maria do Carmo Costa et al. PROGRESS IN NEUROBIOLOGY
- Altered microRNAs in STHdhQ111/HdhQ111 cells: miR-146a targets TBP
- (2010) Mithun Sinha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death
- (2010) Sami Reijonen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Polyglutamine-expanded ataxin-7 upregulates Bax expression by activating p53 in cerebellar and inferior olivary neurons
- (2010) Hung-Li Wang et al. EXPERIMENTAL NEUROLOGY
- Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
- (2010) Daniel J. Ho et al. EXPERIMENTAL NEUROLOGY
- The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2
- (2010) L. Hallen et al. HUMAN MOLECULAR GENETICS
- The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus
- (2010) Edoardo Marcora et al. HUMAN MOLECULAR GENETICS
- Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma
- (2010) Ming-Chang Chiang et al. HUMAN MOLECULAR GENETICS
- Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington’s disease
- (2010) Chiara Soldati et al. JOURNAL OF NEUROCHEMISTRY
- Partial Depletion of CREB-Binding Protein Reduces Life Expectancy in a Mouse Model of Huntington Disease
- (2010) Alexandra M. Klevytska et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
- (2010) Elena Puerta et al. NEUROBIOLOGY OF DISEASE
- HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
- (2010) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease
- (2010) Tyisha Hathorn et al. NEUROBIOLOGY OF DISEASE
- p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons
- (2010) An-Hsun Chou et al. NEUROCHEMISTRY INTERNATIONAL
- Transcriptional Activation of REST by Sp1 in Huntington's Disease Models
- (2010) Myriam Ravache et al. PLoS One
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- Analysis of the Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy of Non-Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease
- (2009) Manuela Marullo et al. BRAIN PATHOLOGY
- Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
- (2009) Hyunkyung Jeong et al. CELL
- Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease
- (2009) Carmela Giampà et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Impaired PGC-1α function in muscle in Huntington's disease
- (2009) Rajnish K. Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model
- (2009) Remko de Pril et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The gene coding for PGC-1α modifies age at onset in Huntington's Disease
- (2009) Patrick Weydt et al. Molecular Neurodegeneration
- Brain-derived neurotrophic factor in neurodegenerative diseases
- (2009) Chiara Zuccato et al. Nature Reviews Neurology
- CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease
- (2009) Yun-Sik Choi et al. NEUROBIOLOGY OF DISEASE
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
- (2009) S. Subramaniam et al. SCIENCE
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- The polyubiquitinUbcgene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease
- (2008) John S. Bett et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
- (2008) Zena DeMarch et al. NEUROBIOLOGY OF DISEASE
- A microRNA-based gene dysregulation pathway in Huntington's disease
- (2007) Rory Johnson et al. NEUROBIOLOGY OF DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started